# PERNIX THERAPEUTICS HOLDINGS, INC.

PERNIX THERAPEUTICS HOLDINGS, INC. is a company headquartered in Morristown, NJ, United States.

## Company overview

- **Legal name:** PERNIX THERAPEUTICS HOLDINGS, INC.
- **Former names in filing history:** GOLF TRUST OF AMERICA INC (1996-11-12 to 2010-03-11)
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Morristown, NJ, United States
- **Incorporated in:** MD
- **Fiscal year end:** December 31
- **SEC CIK:** 0001024126

## About

PERNIX THERAPEUTICS HOLDINGS, INC. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001024126, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2018-03-08, it reported annual revenue of USD 146,068,000; net income of USD -77,141,000; total assets of USD 205,492,000 for the fiscal period ended 2017-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2017 (period ended 2017-12-31)

- **Revenue:** $146.1M (USD 146,068,000)
- **Net income:** -$77.1M (USD -77,141,000)
- **Total assets:** $205.5M (USD 205,492,000)
- **Cash and equivalents:** $32.8M (USD 32,820,000)
- **Operating cash flow:** -$5.9M (USD -5,939,000)
- **Later filings:** Total assets: shown as originally filed; later filings report different values for the same periods.

### FY2016 (period ended 2016-12-31)

- **Revenue:** $140.9M (USD 140,856,000)
- **Net income:** -$169.6M (USD -169,590,000)
- **Total assets:** $310.4M (USD 310,441,000)
- **Cash and equivalents:** $36.4M (USD 36,375,000)
- **Operating cash flow:** -$16.5M (USD -16,501,000)

### FY2015 (period ended 2015-12-31)

- **Revenue:** $175.8M (USD 175,850,000)
- **Net income:** -$148.3M (USD -148,315,000)
- **Total assets:** $511.2M (USD 511,158,000)
- **Cash and equivalents:** $56.1M (USD 56,135,000)
- **Operating cash flow:** -$14.7M (USD -14,749,000)
- **Later filings:** Total assets: shown as originally filed; later filings report different values for the same periods.

### FY2014 (period ended 2014-12-31)

- **Revenue:** $121.7M (USD 121,747,000)
- **Net income:** -$35.3M (USD -35,286,000)
- **Total assets:** $487.4M (USD 487,413,000)
- **Cash and equivalents:** $34.9M (USD 34,855,000)
- **Operating cash flow:** $8.9M (USD 8,896,000)
- **Later filings:** Total assets: shown as originally filed; later filings report different values for the same periods.

## Recent SEC filings

- Form 8-K — filed 2019-06-26 — period 2019-06-11 — FORM 8-K
- Form 8-K — filed 2019-05-21 — period 2019-05-15 — FORM 8-K
- Form 8-K — filed 2019-05-14 — period 2019-05-08 — FORM 8-K
- Form 8-K — filed 2019-05-07 — period 2019-05-01 — FORM 8-K
- Form 8-K — filed 2019-05-06 — period 2019-04-30 — FORM 8-K
- Form 8-K — filed 2019-04-19 — period 2019-04-15 — FORM 8-K
- Form 8-K — filed 2019-04-01 — period 2019-04-01 — 8-K
- Form 8-K — filed 2019-02-27 — period 2019-02-22 — FORM 8-K
- Form 8-K — filed 2019-02-19 — period 2019-02-12 — FORM 8-K
- Form 8-K — filed 2018-11-21 — period 2018-11-15 — 8-K
- Form 10-Q — filed 2018-11-13 — period 2018-09-30 — 10-Q
- Form 8-K — filed 2018-11-13 — period 2018-11-08 — 8-K

---

Updated: 2026-10-23T20:09:28Z

Canonical page: https://altss.com/profile/pernix-therapeutics-holdings-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology